Annual Current Liabilities
$25.89 M
+$16.18 M+166.54%
31 December 2023
Summary:
Enliven Therapeutics annual total current liabilities is currently $25.89 million, with the most recent change of +$16.18 million (+166.54%) on 31 December 2023. During the last 3 years, it has risen by +$24.42 million (+1651.96%). ELVN annual current liabilities is now at all-time high.ELVN Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$17.03 M
-$5.08 M-22.97%
30 September 2024
Summary:
Enliven Therapeutics quarterly total current liabilities is currently $17.03 million, with the most recent change of -$5.08 million (-22.97%) on 30 September 2024. Over the past year, it has increased by +$4.95 million (+40.96%). ELVN quarterly current liabilities is now -34.24% below its all-time high of $25.89 million, reached on 31 December 2023.ELVN Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELVN Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +166.5% | +41.0% |
| 3 y3 years | +1652.0% | - |
| 5 y5 years | - | - |
ELVN Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1652.0% | -34.2% | +196.0% |
| 5 y | 5 years | at high | +1652.0% | -34.2% | +196.0% |
| alltime | all time | at high | +1652.0% | -34.2% | +196.0% |
Enliven Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $17.03 M(-23.0%) |
| June 2024 | - | $22.11 M(-11.7%) |
| Mar 2024 | - | $25.03 M(-3.3%) |
| Dec 2023 | $25.89 M | $25.89 M(+114.4%) |
| Sept 2023 | - | $12.08 M(+32.1%) |
| June 2023 | - | $9.15 M(-16.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $10.94 M(+12.6%) |
| Dec 2022 | $9.71 M(+68.9%) | $9.71 M(+16.6%) |
| Sept 2022 | - | $8.33 M(+44.8%) |
| Dec 2021 | $5.75 M(+289.2%) | - |
| Dec 2021 | - | $5.75 M |
| Dec 2020 | $1.48 M | - |
FAQ
- What is Enliven Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Enliven Therapeutics?
- What is Enliven Therapeutics annual current liabilities year-on-year change?
- What is Enliven Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Enliven Therapeutics?
- What is Enliven Therapeutics quarterly current liabilities year-on-year change?
What is Enliven Therapeutics annual total current liabilities?
The current annual current liabilities of ELVN is $25.89 M
What is the all time high annual current liabilities for Enliven Therapeutics?
Enliven Therapeutics all-time high annual total current liabilities is $25.89 M
What is Enliven Therapeutics annual current liabilities year-on-year change?
Over the past year, ELVN annual total current liabilities has changed by +$16.18 M (+166.54%)
What is Enliven Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ELVN is $17.03 M
What is the all time high quarterly current liabilities for Enliven Therapeutics?
Enliven Therapeutics all-time high quarterly total current liabilities is $25.89 M
What is Enliven Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ELVN quarterly total current liabilities has changed by +$4.95 M (+40.96%)